154 related articles for article (PubMed ID: 20492887)
1. [Etanercept and neoplasms].
García-Rabasco A; Sánchez-Carazo JL; Esteve A
Actas Dermosifiliogr; 2010 May; 101 Suppl 1():88-96. PubMed ID: 20492887
[TBL] [Abstract][Full Text] [Related]
2. [Psoriasiform skin reactions during treatment with etanercept].
Santos-Juanes J; Galache C
Actas Dermosifiliogr; 2010 May; 101 Suppl 1():106-10. PubMed ID: 20492890
[TBL] [Abstract][Full Text] [Related]
3. Safety of etanercept in psoriasis: a critical review.
Sánchez Carazo JL; Mahiques Santos L; Oliver Martinez V
Drug Saf; 2006; 29(8):675-85. PubMed ID: 16872241
[TBL] [Abstract][Full Text] [Related]
4. Etanercept: an overview of its role in the treatment of psoriasis.
Galindo MP; Bartlett BL; Gewirtzman A; Mendoza N; Tremaine AM; Tyring SK
Expert Opin Drug Metab Toxicol; 2008 Mar; 4(3):305-10. PubMed ID: 18363545
[TBL] [Abstract][Full Text] [Related]
5. Etanercept in severe, recalcitrant psoriasis: clinical response, safety profile and predictors of response based on a single institution's experience.
Antoniou C; Dessinioti C; Stratigos A; Avgerinou G; Stavropoulos P; Katsambas A
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):979-82. PubMed ID: 19470056
[No Abstract] [Full Text] [Related]
6. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
Tobin AM; Kirby B
BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
[TBL] [Abstract][Full Text] [Related]
7. Etanercept in psoriasis treatment.
Pietrzak A; Chodorowska G; Urban J; Roliński J; Pietrzak B
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):222-6. PubMed ID: 15314989
[TBL] [Abstract][Full Text] [Related]
8. Targeting tumor necrosis factor alpha. New drugs used to modulate inflammatory diseases.
LaDuca JR; Gaspari AA
Dermatol Clin; 2001 Oct; 19(4):617-35. PubMed ID: 11705350
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of moderate-severe psoriasis with etanercept in patients with chronic human immunodeficiency virus infection].
Barco D; Puig L; Alomar A
Actas Dermosifiliogr; 2010 May; 101 Suppl 1():77-81. PubMed ID: 20492885
[TBL] [Abstract][Full Text] [Related]
10. Etanercept in psoriasis.
Papp KA
Expert Opin Pharmacother; 2004 Oct; 5(10):2139-46. PubMed ID: 15461549
[TBL] [Abstract][Full Text] [Related]
11. Periungual and subungual pyogenic granuloma following anti-TNF-α therapy: is it the first case?
Patruno C; Balato N; Cirillo T; Napolitano M; Ayala F
Dermatol Ther; 2013; 26(6):493-5. PubMed ID: 24552415
[TBL] [Abstract][Full Text] [Related]
12. [Transition of classical systemic treatments to etanercept].
Ferrándiz C; Carrascosa JM
Actas Dermosifiliogr; 2010 May; 101 Suppl 1():45-9. PubMed ID: 20492880
[TBL] [Abstract][Full Text] [Related]
13. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis.
Collamer AN; Battafarano DF
Semin Arthritis Rheum; 2010 Dec; 40(3):233-40. PubMed ID: 20580412
[TBL] [Abstract][Full Text] [Related]
14. Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis.
Saraceno R; Schipani C; Mazzotta A; Esposito M; Di Renzo L; De Lorenzo A; Chimenti S
Pharmacol Res; 2008 Apr; 57(4):290-5. PubMed ID: 18400510
[TBL] [Abstract][Full Text] [Related]
15. Erythema multiforme during anti-tumor necrosis factor treatment for plaque psoriasis.
Ahdout J; Haley JC; Chiu MW
J Am Acad Dermatol; 2010 May; 62(5):874-9. PubMed ID: 19913942
[TBL] [Abstract][Full Text] [Related]
16. Anti-TNF-alpha treatment: a possible promoter in endogenous uveitis? observational report on six patients: occurrence of uveitis following etanercept treatment.
Kakkassery V; Mergler S; Pleyer U
Curr Eye Res; 2010 Aug; 35(8):751-6. PubMed ID: 20673052
[TBL] [Abstract][Full Text] [Related]
17. Two cases of renal cell cancer during immunobiologic therapy for psoriasis.
Zarur FP; d'Almeida LF; Mafort MS; Gusmão PR; Avelleira JC
An Bras Dermatol; 2014; 89(6):1017-8. PubMed ID: 25387517
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients.
Wollina U; Hansel G; Koch A; Schönlebe J; Köstler E; Haroske G
Am J Clin Dermatol; 2008; 9(1):1-14. PubMed ID: 18092839
[TBL] [Abstract][Full Text] [Related]
19. Manifestation of Crohn's disease in a young woman during the course of treatment for severe form of chronic plaque psoriasis with etanercept.
Tichy M; Hercogova J
Dermatol Ther; 2014; 27(4):211-4. PubMed ID: 24548537
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of action of etanercept in psoriasis.
Tan JK; Aphale A; Malaviya R; Sun Y; Gottlieb AB
J Investig Dermatol Symp Proc; 2007 May; 12(1):38-45. PubMed ID: 17502868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
